We are live on ! Find out more
ALGS icon

Aligos Therapeutics
ALGS

51 hedge funds and large institutions have $749M invested in Aligos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.86% more ownership

Funds ownership: 0% → 2.86% (+2.9%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$76.5M
2
VC
Vivo Capital
California
+$69.1M
3
VVM
Versant Venture Management
California
+$64.1M
4
NHAS
Novo Holdings A/S
Denmark
+$50.9M
5
HA
HHLR Advisors
Cayman Islands
+$42.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$821K +$578K +1,187 New
MWNA
27
Marshall Wace North America
New York
$611K +$430K +884 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$604K +$426K +874 New
Morgan Stanley
29
Morgan Stanley
New York
$570K +$401K +824 New
SAM
30
Sectoral Asset Management
Quebec, Canada
$517K +$364K +748 New
EMG
31
ETF Managers Group
New Jersey
$482K +$361K +742 New
N
32
Nuveen
North Carolina
$458K +$322K +662 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$422K +$298K +611 New
Alyeska Investment Group
34
Alyeska Investment Group
Illinois
$415K +$292K +600 New
GSWM
35
Golden State Wealth Management
California
$411K +$289K +594 New
CCM
36
CAAS Capital Management
New York
$277K +$195K +400 New
Bank of America
37
Bank of America
North Carolina
$237K +$168K +344 New
Deutsche Bank
38
Deutsche Bank
Germany
$196K +$138K +283 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$158K +$111K +228 New
Wells Fargo
40
Wells Fargo
California
$145K +$102K +210 New
DKCM
41
Davidson Kempner Capital Management
New York
$138K +$97.4K +200 New
SO
42
STRS Ohio
Ohio
$69K +$48.7K +100 New
Citigroup
43
Citigroup
New York
$52K +$37K +76 New
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$49K +$30.7K +63 New
UBS Group
45
UBS Group
Switzerland
$46K +$32.6K +67 New
Legal & General Group
46
Legal & General Group
United Kingdom
$29K +$20.5K +42 New
AIP
47
Ameritas Investment Partners
Nebraska
$23K +$16.6K +34 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$15K +$10.7K +22 New
TRCT
49
Tower Research Capital (TRC)
New York
$14K +$9.74K +20 New
PAM
50
Panagora Asset Management
Massachusetts
$1K +$487 +1 New
1
2
3

ALGS Hedge Fund Activity: Q4 2020 in Review

51 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Aligos Therapeutics (ALGS) for Q4 2020, worth a combined $749M.

Buyers outnumbered sellers: 51 funds opened new ALGS positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $76.5M.

  • 51 institutional investors held Aligos Therapeutics (ALGS) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $749M of Aligos Therapeutics stock for Q4 2020.
  • 51 funds opened new Aligos Therapeutics positions in Q4 2020 and 0 closed out, a net change of +51 holders.
  • The largest Aligos Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $76.5M added.

Based on aggregated 13F filings for Q4 2020.